Asia Latin America Central & Eastern Europe, Western Asia, and Africa

For further Value in Health Regional Issues features, such as Articles in Press, videos, etc., and to view past Value in Health Regional Issues volumes, view the Value in Health Regional Issues HealthAdvance page at Elsevier.

Volume 2 Issue 2 (SEPTEMBER 2013)
Featured Article Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary
Kalo, et al. describe the capacity building for health technology assessment (HTA) in Hungary and the contribution of the ISPOR Hungary Chapter to this process. The Hungarian experience may be relevant to low and medium income countries seeking to use HTA in health policy decisions.
Issue Highlights
ECONOMIC STUDY
Cost-Effectiveness Analysis of Aripiprazole Augmentation Treatment of Patients with Major Depressive Disorder Compared to Olanzapine and Quetiapine Augmentation in Turkey: A Microsimulation Approach
Major depressive disorder (MDD) is a health condition with substantial burden on patients, their families and the society. In this article, the authors report on an economic evaluation estimating the cost-effectiveness of aripiprazole in Turkey.
PATIENT-REPORTED OUTCOMES (PRO) OR QUALITY OF LIFE (QOL) STUDY
The assessment of quality of life (QoL) in children is methodologically challenging, and this topic has not been widely studied. This article highlights considerations that should be taken into account when developing QoL assessments focusing on HIV/AIDS interventions for children in low-income countries.
CLINICAL OUTCOMES STUDY
Clinical Burden of Invasive Pneumococcal Disease in Selected Developing Countries
Invasive Pneumococcal Disease (IPD) is associated with a high mortality rate. In this literature review, the authors assess the clinical burden of IPD in selected developing countries.
HEALTH POLICY ANALYSIS
What Influences Recommendations Issued by the Agency for Health Technology Assessment in Poland? A Glimpse Into Decision Makers' Preferences
Niewada, et al. reviewed 344 recommendations from The Agency for Health Technology Assessment in Poland (AHTAPol) and evaluated the factors that are associated with positive (supporting public funding) and negative recommendations.
Also in this Issue
EDITORIAL
ECONOMIC STUDY
PATIENT-REPORTED OUTCOMES (PRO) OR QUALITY OF LIFE (QOL) STUDY
CLINICAL OUTCOMES STUDY
Economic Burden of Individual Suffering from Atrial Fibrillation Related Stroke In China
Shanlian Hu, MSc, Lin Zhan, MSc, Bao Liu, MD, PhD, Yue Gao, MD, Yan Li, MD5, Rongsheng Tong, MD, Lin Wu, MD, Bo Yu, MD, Shen Gao, MD
HEALTH POLICY ANALYSIS
CONCEPTUAL PAPERS

Reviewer Acknowledgement

Previous Issues